1h Free Analyst Time
The publisher has been monitoring the drug delivery devices market and it is poised to grow by $77.26 bn during 2022-2026, progressing at a CAGR of 6.28% during the forecast period. The report on the drug delivery devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic conditions and increased strategic developments.
The drug delivery devices market analysis includes the route of administration and geographic landscape.
The drug delivery devices market is segmented as below:
By Route of Administration
- Oral
- Injectable
- Pulmonary
- Others
By Geography
- North America
- Europe
- Asia
- ROW
This study identifies the increase in regulatory approvals for drug delivery devices as one of the prime reasons driving the drug delivery devices market growth during the next few years.
The report on drug delivery devices market covers the following areas:
- Drug delivery devices market sizing
- Drug delivery devices market forecast
- Drug delivery devices market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading drug delivery devices market vendors that include 3M Co., AbbVie Inc., Antares Pharma Inc., Becton Dickinson and Co., BIOCORP Production, F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Also, the drug delivery devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market size 2021
- Market segment analysis
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Route of administration
- Market segments
- Comparison by Route of administration
- Oral - Market size and forecast 2021-2026
- Injectable - Market size and forecast 2021-2026
- Pulmonary - Market size and forecast 2021-2026
- Others - Market size and forecast 2021-2026
- Market opportunity by Route of administration
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Competitive Scenario
- Overview
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- 3M Co.
- AbbVie Inc.
- Antares Pharma Inc.
- Becton Dickinson and Co.
- BIOCORP Production
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Novartis AG
- Pfizer Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ()
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Route of administration - Market share 2021-2026 (%)
- Comparison by Route of administration
- Oral - Market size and forecast 2021-2026 ()
- Oral - Year-over-year growth 2021-2026 (%)
- Injectable - Market size and forecast 2021-2026 ()
- Injectable - Year-over-year growth 2021-2026 (%)
- Pulmonary - Market size and forecast 2021-2026 ()
- Pulmonary - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026 ()
- Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by Route of administration
- Customer landscape
- Market share by geography 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ()
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ()
- Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ()
- Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ()
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity by geography ()
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- 3M Co. - Overview
- 3M Co. - Business segments
- 3M Co. - Key offerings
- 3M Co. - Key customers
- 3M Co. - Segment focus
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Key customers
- AbbVie Inc. - Segment focus
- Antares Pharma Inc. - Overview
- Antares Pharma Inc. - Business segments
- Antares Pharma Inc. - Key offerings
- Antares Pharma Inc. - Key customers
- Antares Pharma Inc. - Segment focus
- Becton Dickinson and Co. - Overview
- Becton Dickinson and Co. - Business segments
- Becton Dickinson and Co. - Key offerings
- Becton Dickinson and Co. - Key customers
- Becton Dickinson and Co. - Segment focus
- BIOCORP Production - Overview
- BIOCORP Production - Business segments
- BIOCORP Production - Key offerings
- BIOCORP Production - Key customers
- BIOCORP Production - Segment focus
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Key customers
- F. Hoffmann La Roche Ltd. - Segment focus
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Key customers
- Johnson and Johnson Inc. - Segment focus
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key offerings
- Novartis AG - Key customers
- Novartis AG - Segment focus
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Key customers
- Pfizer Inc. - Segment focus
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Key customers
- Teva Pharmaceutical Industries Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global drug delivery devices market: 3M Co., AbbVie Inc., Antares Pharma Inc., Becton Dickinson and Co., BIOCORP Production, F. Hoffmann La Roche Ltd., Johnson and Johnson Inc., Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increase in regulatory approvals for drug delivery devices.'
According to the report, one of the major drivers for this market is the growing prevalence of chronic conditions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Co.
- AbbVie Inc.
- Antares Pharma Inc.
- Becton Dickinson and Co.
- BIOCORP Production
- F. Hoffmann La Roche Ltd.
- Johnson and Johnson Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
